Neonatal Antibiotics and Prematurity Are Associated with an Increased Risk of Functional Gastrointestinal Disorders in the First Year of Life.


Journal

The Journal of pediatrics
ISSN: 1097-6833
Titre abrégé: J Pediatr
Pays: United States
ID NLM: 0375410

Informations de publication

Date de publication:
09 2019
Historique:
received: 14 12 2018
revised: 24 04 2019
accepted: 29 04 2019
pubmed: 16 6 2019
medline: 14 5 2020
entrez: 16 6 2019
Statut: ppublish

Résumé

To assess the prevalence of functional gastrointestinal disorders (FGIDs) in the first year of life and the influence of different neonatal factors on development of FGIDs. A prospective cohort multicenter study including neonates, consecutively enrolled at birth, and followed up until 1 year. Gestational age, neonatal antibiotic administration, duration of hospitalization, mode of delivery, birth weight, and feeding pattern were recorded. FGIDs were classified according to Rome III criteria and assessed at 1, 3, 6, and 12 months of life. Among 1152 newborns enrolled, 934 (81.1%) completed the study, 302 (32%) were newborns born preterm, 320 (34%) had neonatal antibiotics, and 718 (76.9%) had at least 1 FGID according to Rome III criteria (443 [47.4%] infantile colic, 374 [40.0%] regurgitation, 297 [31.8%] infant dyschezia, 248 [26.6%] functional constipation, and 34 [3.6%] functional diarrhea) throughout the first year of life. The proportion of infants born preterm presenting with FGIDs (86%) was significantly greater compared with infants born full term (72.5%) (χ We found a high rate FGIDs in infants, likely related to the population recruited, the long observation period, the diagnosis based on Rome III criteria, and parental reports. Preterm delivery and neonatal use of antibiotics in the first months of life are associated with an increased incidence of FGIDs, particularly infantile colic and regurgitation. In our population, cesarean delivery and feeding pattern at 1 month of life emerged as additional risk factors for infant dyschezia and functional diarrhea. Other neonatal factors associated with FGIDs need to be further explored.

Identifiants

pubmed: 31201028
pii: S0022-3476(19)30544-X
doi: 10.1016/j.jpeds.2019.04.061
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

44-51

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Silvia Salvatore (S)

Unit of Pediatrics and Neonatology, "F. Del Ponte" Hospital, Dipartimento di Medicina e Chirurgia University of Insubria, Varese, Italy.

Maria Elisabetta Baldassarre (ME)

Department of Biomedical Science and Human Oncology, Aldo Moro University of Bari, Bari, Italy. Electronic address: mariellabaldassarre@gmail.com.

Antonio Di Mauro (A)

Department of Biomedical Science and Human Oncology, Aldo Moro University of Bari, Bari, Italy.

Nicola Laforgia (N)

Department of Biomedical Science and Human Oncology, Aldo Moro University of Bari, Bari, Italy.

Silvio Tafuri (S)

Department of Biomedical Science and Human Oncology, Aldo Moro University of Bari, Bari, Italy.

Francesco Paolo Bianchi (FP)

Department of Biomedical Science and Human Oncology, Aldo Moro University of Bari, Bari, Italy.

Enzo Dattoli (E)

Unit of Pediatrics and Neonatology, "F. Del Ponte" Hospital, Dipartimento di Medicina e Chirurgia University of Insubria, Varese, Italy.

Lucia Morando (L)

Unit of Pediatrics and Neonatology, "F. Del Ponte" Hospital, Dipartimento di Medicina e Chirurgia University of Insubria, Varese, Italy.

Licia Pensabene (L)

Department of Pediatrics, "Magna Graecia" University, Viale Pio X, Catanzaro, Italy.

Fabio Meneghin (F)

Department of Pediatrics, Vittore Buzzi Children's Hospital, University of Milan, Milan, Italy.

Dario Dilillo (D)

Department of Pediatrics, Vittore Buzzi Children's Hospital, University of Milan, Milan, Italy.

Valentina Mancini (V)

Pediatric Unit, Saronno Hospital, Saronno, Italy.

Valentina Talarico (V)

Department of Pediatrics, "Magna Graecia" University, Viale Pio X, Catanzaro, Italy.

Francesco Tandoi (F)

Unit of Pediatrics and Neonatology, "F. Del Ponte" Hospital, Dipartimento di Medicina e Chirurgia University of Insubria, Varese, Italy.

Gianvincenzo Zuccotti (G)

Department of Pediatrics, Vittore Buzzi Children's Hospital, University of Milan, Milan, Italy.

Massimo Agosti (M)

Unit of Pediatrics and Neonatology, "F. Del Ponte" Hospital, Dipartimento di Medicina e Chirurgia University of Insubria, Varese, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH